NovAccess Global Inc. – OTC:XSNX

Add to watchlist

-0.00

-97%

Market closed

Open in about 3 hours

-23.08%

month

-23.08%

quarter

-56.52%

year

Market Cap	2.93M
Enterprise value	N/A

P/E	-1.09
EV/Sales	N/A
EV/EBITDA	-0.01
Price/Sales	N/A
Price/Book	N/A
PEG ratio	-0.01
EPS	-0.11

Revenue	N/A
EBITDA	-2.20M
Income	-2.58M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

NovAccess Global Inc. (OTC:XSNX): Profit margin
Mar 2023	0	453.76K
Jun 2023	0	-779.63K
Sep 2023	0	-1.76M
Mar 2024	0	-492.59K

NovAccess Global Inc. (OTC:XSNX): Earnings per share (EPS)
2023-02-14	-0.13133	-0.13864

NovAccess Global Inc. (OTC:XSNX): Debt to assets
Mar 2023	103459	5.83M	5635.23%
Jun 2023	177027	6.40M	3620.91%
Sep 2023	62248	7.86M	12628.09%
Mar 2024	85645	6.93M	8102.68%

NovAccess Global Inc. (OTC:XSNX): Cash Flow
Mar 2023	-197.20K	180.25K
Jun 2023	-113.27K	152.75K
Sep 2023	-154.85K	114.8K
Mar 2024	-61.19K	69.5K

NovAccess Global alternative data

NovAccess Global Inc. (OTC:XSNX): Employee count
Aug 2023	2
Sep 2023	2
Oct 2023	2
Nov 2023	2
Dec 2023	2
Jan 2024	2
Feb 2024	2
Mar 2024	3
Apr 2024	3
May 2024	3
Jun 2024	3
Jul 2024	3

NovAccess Global
Insider Trading

NovAccess Global Inc. (OTC:XSNX): Insider trades (number of shares)
Period	Buy	Sel
Jan 2022	250000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	20 Jan 2022	LAIRD NEIL J officer: Chief Financial Officer officer: Chief Financial Officer	Common Stock, no par value	250,000	$0.2	$50,000
Purchase	23 Oct 2007	ANDERSON THOMAS A director director	Option	1,500,000	$0.36	$540,000
Sale	27 Apr 2006	ALTOUNIAN BRIAN director director	Common Stock	474,000	$1.79	$846,090
Sale	17 Apr 2006	ALTOUNIAN BRIAN director director	Common Stock	500,000	$2.03	$1,015,000
Sale	31 Jan 2006	ALTOUNIAN BRIAN director director	Common Stock	300,000	N/A	N/A

XSNX insider trading transactions

NovAccess Global
Latest News

Tuesday, 7 May 2024
11:25	NovAccess Global Advisory on Annual Meeting of Shareholders	accesswire.com
Tuesday, 30 April 2024
09:00	NovAccess Global Announces New License to Advance its Immunotherapy Platform	accesswire.com
Friday, 1 March 2024
09:00	NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders	accesswire.com
Tuesday, 2 January 2024
08:00	NovAccess Global Announces $10.7 Million Financing	accesswire.com
Friday, 1 December 2023
16:51	NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit	Newsfile Corp
Thursday, 16 February 2023
09:00	NovAccess Global to Present at World Orphan Drug Congress	Accesswire
Friday, 3 February 2023
09:00	NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress	Accesswire

Frequently Asked Questions (FAQ)

What's the price of NovAccess Global stock today?

One share of NovAccess Global stock can currently be purchased for approximately $0.
When is NovAccess Global's next earnings date?

Unfortunately, NovAccess Global's (XSNX) next earnings date is currently unknown.
Does NovAccess Global pay dividends?

No, NovAccess Global does not pay dividends.
How much money does NovAccess Global make?

NovAccess Global has a market capitalization of 2.93M. NovAccess Global made a loss 4.77M US dollars in net income (profit) last year or -$0.14 on an earnings per share basis.
What is NovAccess Global's stock symbol?

NovAccess Global Inc. is traded on the OTC under the ticker symbol "XSNX".
What is NovAccess Global's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of NovAccess Global?

Shares of NovAccess Global can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does NovAccess Global have?

As Jul 2024, NovAccess Global employs 3 workers.
When NovAccess Global went public?

NovAccess Global Inc. is publicly traded company for more then 27 years since IPO on 21 Sep 1998.
What is NovAccess Global's official website?

The official website for NovAccess Global is novaccessglobal.com.
Where are NovAccess Global's headquarters?

NovAccess Global is headquartered at 8834 Mayfield Road, Chesterland, OH.
How can i contact NovAccess Global?

NovAccess Global's mailing address is 8834 Mayfield Road, Chesterland, OH and company can be reached via phone at +94 93308060.

NovAccess Global Inc.

novaccessglobal.com

Exchange:

OTC

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

+94 93308060

8834 Mayfield Road
Chesterland, OH 44023

CIK: 0001039466
ISIN: US67001N1072
CUSIP: 67001N107